The paywalled retraction notice simply cites a “nonscientific reason.” Cody Mooneyhan, the director of publications at the journal, declined to provide further details, and the authors have provided different accounts of what happened: The paper’s corresponding author, John Yu, told Retraction Watch that he requested the retraction because the first author, Chia‐Ti Tsai, refused to sign the journal’s copyright agreement. Tsai, a professor in the Department of Internal Medicine at National Taiwan University in Taipei, told us he was “not notified before the paper was submitted.” Continue reading Authors retract heart disease paper for “nonscientific reason”
A BMJ journal has retracted a 2017 paper that made a false claim about the clinical trial in question.
The Acupuncture in Medicine paper reported the results of a clinical trial about the impact of acupuncture and Chinese herbal medicine on stroke, gathered from one center. However, in November, the editors of the journal discovered that the authors had completed the trial at three centers, and had already published the data in Scientific Reports in 2016. The authors say the duplication and misrepresentation of the data stemmed from “confusion and misunderstanding.” Continue reading Authors claim clinical trial data came from one center. It came from three.
The papers were part of a collaboration funded by the U.S. National Institutes of Health, which focused on solving protein structures. Adam Godzik, the senior author, told Retraction Watch that all papers had to be approved by a special committee before being submitted to a journal. Given the scale of the collaboration, the committee for the Joint Center for Structural Genomics (JCSG) would assess whether researchers who had made a previous contribution to the work should be added as authors.
Proteins: Structure, Function, and Bioinformatics retracted both papers after Godzik informed the editor in August 2014 that neither article had undergone the required review before being submitted to the journal. Although Wiley agreed to the retractions in an email to Godzik in September 2014, the papers were only pulled in January—more than three years later. Continue reading Author: “The retractions were about bureaucracy, not science”
A journal is retracting a paper after it discovered researchers gave a child the wrong supplement for more than a year.
Rhiannon Bugno, managing editor for Biological Psychiatry, told Retraction Watch the mix-up did not put the patient at risk. However, the mistake was enough for the journal’s editor, John Krystal, of Yale University, to request the retraction of a 2016 paper describing the young girl’s experience taking the compound,“Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement.”
Originally published June 17, 2016, the paper was retracted Jan. 15. Led by corresponding author Xavier Altafaj, of the University of Barcelona (UB) and Bellvitge Biomedical Research Institute (IDIBELL), researchers described using an amino acid, D-serine, to treat a child with a rare genetic disorder that affects neurons.
According to the notice, the researchers did use D-serine in lab work used as proof-of-concept; however, when it came time to try it in the patient, as a result of a “communication error:”
A patient’s “unusual” brain cyst excited several researchers in China so much they published a paper about it in a major journal. Soon a reader identified a glaring mistake: the authors had described the cause of the cyst incorrectly.
A month after the paper appeared online in November 2016, the reader — a neurologist — published a letter in the journal, pointing out the incorrect diagnosis. In their response, the authors acknowledged the mistake but said it had occurred not because they had misdiagnosed the patient, but because the diagnosis had been mistranslated from Chinese to English.
The editors of Neurology retracted the paper because of the error and published a new version with the correct diagnosis on the same day, June 6.
Although we did not hear back from the paper’s two corresponding authors—Jun Guo and Guan Sun—the journal published a string of letters that chronicles the case.
Here’s the retraction (and replacement) notice:
The study’s first and corresponding author of the study in the British Journal of Sports Medicine — Julie Stang from the Norwegian School of Sports Sciences in Oslo — told us the authors had struggled to obtain ethical approval for the research, but believed the issue had been resolved.
However, earlier this year, a member of an ethical committee wrote an article in the Norwegian press about his concerns regarding the study, which tested the effects of three drugs on top athletes’ breathing. In it, he said the Regional Committees for medical and health professional research ethics (REC) had not approved the study, as members were concerned the presumably healthy athletes were being exposed to drugs used to treat asthma, which could enhance their performance.
Stang has denied that the study had anything to do with boosting athletic performance.
Stein Evensen, the committee member who wrote the article, declined to comment beyond the published text. So we’ve gotten the kronikk article translated from Norwegian using One Hour Translation. It reads: Continue reading Authors retract paper lacking approval to study asthma in athletes
Interestingly, two authors of the newly retracted papers — Yu-Tao Xiang from the University of Macau in China and Gabor Ungvari from the University of Western Australia — also recently co-authored another paper on an entirely different topic that has received a lengthy correction. That paper — on the use of organs from executed prisoners in China — raised controversy for allegedly reporting a “sanitized” account of the practice. The correction notice, in the Journal of Medical Ethics, was accompanied by a critics’ rebuttal to the paper.
According to Xiang, the newly retracted papers in The Journal of ECT — which examined the efficacy of ECT in treating schizophrenia — were pulled due to “genuine errors” resulting from differences in language. All the authors agree with the retraction, Xiang noted.
The paper — about an “extremely rare” instance where a fetus was diagnosed with both a form of dwarfism and a chromosomal condition known as Klinefelter syndrome — was retracted from Case Reports in Obstetrics and Gynecology (CROG).
The first author of the paper told us the report was the result of a “big misunderstanding” between her and a former colleague, and she alerted the journal as soon as she noticed the case had already been reported in BMC Pediatrics.
It might not be a first – although we can’t find another example — but a mental health journal has reinstated an article it retracted four years ago.
The retracted retraction notice appears in the August issue of the Journal of Neurology, Neurosurgery & Psychiatry, a BMJ title, and refers to a 2005 article describing an alarming case of treatment-related emotional problems in a patient with cluster headaches.
These headaches, which often strike behind the eyes, are akin to migraines and have been dubbed “suicide headaches” because they are so intensely painful that many sufferers have said that death would be a preferable fate. (Think: “It beats a poke in the eye with a sharp stick.”)
The patient had been taking high doses of the drug methysergide and began to experience Continue reading Double negatives: Four years later, a journal restores retracted headache paper